Associates of Cape Cod, Inc. and Beacon Diagnostics® laboratory are not responsible or liable for the content of external resource links. Only the operators of the linked pages are responsible for their content.


Reference List
1.   Alexander B.D.  Diagnosis of fungal infection: New technologies for the mycology laboratory. Transplant Infectious Disease 4 (Supplement 3):32-37 (2002)

2.   Luis Ostrosky-Zeichner, Barbara D. Alexander,  Daniel H. Kett,  Jose Vazquez,  Peter G. Pappas,  Fumihiro Saeki, Paul A. Ketchum, John Wingard, Robert Schiff, Hiroshi Tamura, Malcolm A. Finkelman, and John H. Rex. Multicenter clinical evaluation of the (1→3)-ß-D-glucan assay as as aid to diagnosis of fungal infections in humans.  

3.   Ascioglu S., Rex J. H., de Pauw B., Bennett J. E., Bille J., Crokaert F., Denning D. W., Donnelly J. P., Edwards J. E., Erjavec Z., Fiere D., Lortholary O., Maertens J., Meis J. F., Patterson T. F., Ritter J., Sellesag D., Shah P. M., Stevens D. A., and Walsh T. J.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clinical Infectious Diseases 34:7-14 (2002)

4.   Cheung N. V., Modak S., Vickers A., and Knuckles B. Orally administered ß-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunology Immunotherapy 51:557-564 (2002)

5.   Chiba M., Mikami K., Iizuka M., Yukawa M., Watanabe S., Takazoe M., Fukushima T., Koganei K., and Kishibe T. Elevated plasma (1→3)-ß-D-glucan, a fungal cell wall constituent, in a subgroup of Crohns Disease. Scandinavian Journal of Gastroenterology 36(4):447-448 (2001)

6.   Hong F., Hansen R. D., Yan J., Allendorf D. J., Baran J. T., Ostroff G. R., and Ross G. D. ß-glucan functions as an adjuvant for monoclonal antibody immunotherapy recruiting tumoricidal granulocytes as killer cells. Cancer Research 63:9023-9031 (2003)

7.   Hossain M. A., Miyazaki T., Mitsutake K., Kakeya H., Yamamoto Y., Yanagihara K., Kawamura S., Otsubo T, Hirakata Y., Tashiro T., and Kohno S. Comparison between Wako-WB003 and Fungitec G tests for the detection of (1→3)-ß-D-glucan in systemic mycosis. Journal of Clinical Laboratory Analysis 11:73-77 (1997)

8.   Ikemura K., Ikegami K., Shimazu T., Yoshioka T., and Sugimoto T. False positive result in limulus test caused by limulus amebocyte lysate reactive material in immunoglobulin products. Journal of Clinical Microbiology 27(9):1965-1968 (1989)

9.   Ishizuka Y., Tsukada H., Gejyo F. Interference of (1→3)-ß-D-glucan administration in the measurement of plasma (1→3)-ß-D-glucan. Internal Medicine. 43(42):97-101 (2004)

10.   Iwama A., Yoshida M., Miwa A., Obayashi T., Sakamoto S., and Miura Y. Improved survival from fungaemia in patients with haematological malignancies: Analysis of risk factors for death and usefulness of early antifungal therapy. European Journal of Haematology 51:156-160 (1993)

11.   Jones B., and McLintock L. Impact of diagnostic markets on early antifungal therapy. Current Opinion in Infectious Disease 16:521-526 (2003)

12.   Kami M., Tanaka Y., Kanda Y., Ogawa S., Masumoto T., Ohtomo K., Matsumura T., Saito T., Machida U., Kashima T., and Hirai H. Computed tomographic scan of the chest, latex agglutination test and plasma (1→3)-ß-D-glucan assay in early diagnosis on invasive pulmonary aspergillosis: A prospective study of 215 patients. Haematologica 85:745-752 (2000)

13.   Kato A., Takita T., Furuhashi M., Takahashi T., Maruyama Y., and Hishida A. Elevation of blood (1→3)-ß-D-glucan concentrations in hemodialysis patients. Nephron 89:15-19 (2001)

14.   Kawayama T., Fujiki R., Honda J., Rikimaru T., and Aizawa H. High concentration of (1→3)-ß-D-glucan in BAL fluid in patients with acute eosinophilic pneumonia. Chest Journal123:1302-1307 (2003)

15.   Kimura Y., Nakao A., Tamura H., Tanaka S., and Takagi H. Clinical and experimental studies of the limulus test after digestive surgery. Japan J. Surg. 25:790-794 (1995)

16.   Kondori N., Edebo L., and Mattsby-Baltzer I. Circulating (1→3)-ß-D-glucan and Immunoglobin G subclass antibodies to candia albicans cell wall antigens in patients with systemic candidiasis. Clinical and diagnostic Laboratory Immunology. 11(2):344-350 (2004)

17.   Kusanagi H., Shimura T., and Teramoto A.  The usefulness of fluconazole administration and ß-D-glucan measurement in neurosurgical patients with deep-seated mycosis.  No Shinkei Geka 28(8):685-690 (2000)

18.   Matsumoto Y., Matsuda S., and Tegoshi T. Yeast glucan in the cyst wall of pneumocystis carinii. Journal of Protozool. 36(1):215-225 (1989)

19.   Mitsutake K., Miyazaki T., Tashiro T., Yamamoto Y., Kakeya H., Otsubo T., Kawamura S., Hossain M. A., Noda T., Hirakata Y., and Kohno S. Enolase antigen, mannan antigen, candtec antigen, and beta-glucan in patients with candidemia. Journal of Clinical Microbiology 34(8):1918-1921 (1996)

20.   Miyazaki T., Kohno S., Koga H., Kaku M., Mitsutake K., Maesaki S., Yasuoka A., Hara K., Tanaka S., and Tamura H. G test, a new direct method for diagnosis of candida infection: Comparison with assays for beta-glucan and mannan antigen in a rabbit model of systemic candidasis. Journal of Clinical Laboratory analysis 6:315-318 (1992)

21.   Miyazaki T., Kohno S., Mitsutake K., Maesaki S., Tanaka K., and Hara K. (1→3)-ß-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. Journal of Clinical Laboratory Analysis 9:334-339 (1995)

22.   Miyazaki T., Kohno S., Mitsutake K., Maesaki S., Tanaka K., Ishikawa N., and Hara K. Plasma (1→3)-ß-D-glucan and fungal antigenemia in Patients with candidemia, aspergillosis, and cryptococcosis. Journal of Clinical Microbiology December:3115-3118 (1995)

23.   Nakao A., Kato H., Kanbe T., Tanaka K., Tamura H., Tanaka S., and Takagi H. Quantitative assay of (1→3)-ß-D-glucan in culture media of candida albicans using the G-test. European Surgical Journal 26:194-200 (1994)

24.   Nakao A., Tamura H., Tanaka S., Kawagoe T., and Takagi H. (1→3)-ß-D-glucan determination in rat organs with limulus coagulation factor G. Research in Experimental Medicine 196:339-343 (1997)

25.   Nakao A., Yasui M., Kawagoe T., Tamura H., Tanaka S., and Takagi H.  False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellularcarcinoma with cirrhosis. Hepato-Gastroenterology 44:1413-1418 (1997)

26.   Nichterlein T., Buchheidt D., Hein A., Becker K. P., Mosbach K., and Kretschmar M. Comparison of glucan detection and galactomannan enzyme immunoassay in gastrointestinal ans systemic murine candidiasis. Diagnostic Microbiology and Infectious Disease. 46:103-108 (2003)

27.   Obayashi T., Yoshida M., Tamura H., Aketagawa J., Tanaka S., and Kawai T.  Determination of plasma (1→3)-ß-D-glucan: A new diagnostic aid to deep mycosis.  Journal of Medical and Veterinary Mycology 30:275-280 (1992)

28.   Obayashi T., Yoshida M., Mori T., Goto H., Yasuoka A., Iwasaki H., Teshima H., Kohno S., Horiuchi A., Ito A., Yamaguchi H., Shimada K., and Kawai T. Plasma (1→3)-ß-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. The Lancet 345:17-20 (1995)

29.   Odabasi Z., Mattiuzzi G., Estey E., Kantarjian H., Saeki F., Ridge R., Ketchum P., Finkelman M., Rex J. and Ostrosky-Zeichner L. (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections:  Validation, cutoff development, and performance in patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Clinical Infectious Diseases. 39:199-205.

30.   Pazos C., Ponto J., and Del Palacio A. Contribution of (1→3)-ß-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: A comparison with serial screening for circulating galactomanna. Journal of Clinical Microbiology 43(1): 299-305 (2005)

31.   Reiss E., Obayashi T., Orle K., Yoshida M., and Zancope-Oliveira R. M. Non-culture based diagnostic tests for mycotic infections. Medical Mycology 38(1):147-159 (2000)

32.   Tamura H., Arimoto Y., Tanaka S., Yoshida, Obayashi T., and Kawai T. Automated kinetic assay for endotoxin and (1→3)-ß-D-glucan in human blood. Clinica Chimica Acta 226:109-112 (1994)

33.   Tanaka S., Aketagawa J., Takahashi S., Shibata Y., Tsumuraya Y., and Hashimoto Y. Activation of limulus coagulation factor G by (1→3)-ß-D-glucans. Carbohydrate Research 218:167-174 (1991)

34.   Usami M., Ohata A., Horiuchi T., Nagasawa K., Wakabayashi T., and Tanaka S. Positive (1→3)-ß-D-glucan in blood components and release of (1→3)-ß-D-glucan from depth-type membrane filters for blood processing. Transfusion 42:1189-1195 (2002)

35.   Verweij, P.E., and Meis J.F.G.M. Microbiological diagnosis of invasive fungal infections in transplant recipients. Transplant Infectious Disease 2:80-87 (2000)

36.   Yasuoka A., Tachikawa N., Shimada K., Kimura S., and Oka S. (1→3)-ß-D-glucan as a quantitative serological marker for pneumocyitis carinni pneumonia. Clinical and Diagnostic Laboratory Immunology 3(2):197-199 (1996)

37.   Yoshida M., Roth R., Grunfeld C., Feingold K., and Levin J. Soluble (1→3)-ß-D-glucan purified from candida albicans: Biologic effects and distribution in blood and organs in rabbits. Journal of Laboratory Clinical Medicine 128 (1):103-114 (1996)

38.   Yoshida M., Roth R., Grunfeld C., Feingold K., and Levin J. Pharmacokinetics, biological effects and distribution of (1→3)-ß-D-glucan in blood and organs in rabbits. Mediators of Inflammation 6:279-283 (1997)

39.   Yoshida, M. Obayashi T., Iwama A., Ito M., Tsunoda S., Suzuki T., Muroi K., Ohta M., Sakamoto S., and Miura Y. Detection of plasma (1→3)-ß-D-glucan in patients with fusarium, trichosporon, saccharomyces and acremonium fungaemias. Journal of Medical & Veterinary Mycology 35:371-374 (1997)

40.   Yoshia M. Infections in patients with hematological diseases: Recent advances in serological diagnosis and empiric therapy. International Journal of Hematology 66:279-289 (1997)

41.   Yuasa K., and Goto H. (1→3)-ß-D-glucan in patients with pulmonary aspergilloma. Mediators of Inflammation Vol. 6:285-287 (1997)